Boston Scientific Financial Analyst II - Electrophysiology EP FP & 

United States, Minnesota 

458685662

About the role:

The Financial Analyst II will be responsible for supporting the US SG&A functions for the Electrophysiology (EP) Division. The ideal candidate will have strong analytical, communication, planning, and process skills. This position requires an outgoing candidate that can build strong relationships with business partners to optimize financial planning, reporting, and analysis. Additional responsibilities include facilitating month-end close activities, including journal entry preparation, and support of Value Improvement Program (VIP) initiatives. This position reports to the Director Finance Manager, Electrophysiology.

Your responsibilities will include:

• Develop detailed financial forecasts, including strategic plan, annual operating plan, and quarterly forecasts; incorporating historic, trended, and current business information for operating expenses, headcount and capital expenditures
• Monitor functional and departmental spending versus budget by highlighting material variances using system generated detail and trend reports
• Prepare journal entries and assist in month end close, as needed, to ensure proper accounting at the functional and departmental level
• Prepare and distribute financial reports and packages by gathering and analyzing information related to current performance
• Perform financial analysis, as directed by management, and recommend alternative courses of action by utilizing appropriate financial tools
• Develop and utilize sound financial processes
• Drive continuous improvement of processes and analytics
• Document and maintain work instructions
• Identify opportunities to improve the efficiency and effectiveness of the systems and internal processes
• Keep the organization's vision and values at the forefront of decision making and action

Required qualifications:

• Bachelor’s degree
• 2+ years of relevant experience
• Experience with Microsoft Office suite (Excel, PowerPoint)
• Excellent oral and written communication skills
• Strong financial analysis, communication, organization, and prioritization skills
• Strong attention to detail and data accuracy

Preferred qualifications:

• Bachelor’s degree in Finance, Accounting, or similar field
• Experience with financial modeling, Microsoft Access, SAP, Hyperion
• Must be a quick learner and able to assertively engage with internal and external customers
• Ability to multi-task and set priorities/execute in a fast-paced organization
• Ability to work in a dynamic environment, adhere to tight deadlines
• Holds self-accountable to a performance metric culture building performance excellence
• Team oriented

Compensation fornon-exempt (hourly), non-sales rolesmay also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).

Compensation forexempt, non-sales rolesmay also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements.

For MA positions:It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.